India, Oct. 4 -- Aarti Pharmalabs, India's largest manufacturer of caffeine and xanthine derivatives, is targeting a 20-25% share of the global market as it expands its product portfolio and manufacturing capabilities. With an established global presence and growing demand for its specialised products, the company is focusing on scaling production and strengthening its position in international markets.

With a market capitalization of Rs. 8,840.37 crore, the shares of Aarti Pharmalabs Limited rose by upto 3.4 percent, reaching a high of Rs. 985.00 from the previous close of Rs. 952.25.

Aarti Pharmalabs At Glance Aarti Pharmalabs Limited (APL) is part of the diversified Aarti Group, which recorded a group turnover of more than Rs. 145 bi...